In NB patient cohorts separated by tumor stage [15] from two different datasets, we found that a more expressed CHL1 gene correlated with better event-free survival rates in patients with both low stage (1, 2, 3, 4S) and high stage (4) disease (S1A Fig). This evidence concerns the gene CHL1 and neoplasm.